Capstone Investment Advisors, LLC Abbott Laboratories Call Options Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $2.18 Million - $2.58 Million	21,800 Added 22.18%	120,100 $13.7 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $3.65 Million - $4.07 Million	36,200 Added 58.29%	98,300 $10.2 Million
Q1 2024 May 01, 2024	SELL	$109.52 - $120.96 $2.97 Million - $3.28 Million	-27,100 Reduced 30.38%	62,100 $7.06 Million
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $4.01 Million - $4.91 Million	44,500 Added 99.55%	89,200 $9.82 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $324,802 - $389,708	3,400 Added 8.23%	44,700 $4.33 Million
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $1.2 Million - $1.34 Million	11,900 Added 40.48%	41,300 $4.5 Million
Q1 2023 May 09, 2023	SELL	$96.86 - $114.01 $6.67 Million - $7.86 Million	-68,900 Reduced 70.09%	29,400 $2.98 Million
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $5.01 Million - $5.88 Million	52,700 Added 115.57%	98,300 $10.8 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $503,152 - $582,556	-5,200 Reduced 10.24%	45,600 $4.41 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $7.47 Million - $9.03 Million	-73,200 Reduced 59.03%	50,800 $5.52 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $24.3 Million - $29.7 Million	-213,300 Reduced 63.24%	124,000 $14.7 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $1.68 Million - $2.05 Million	14,500 Added 4.49%	337,300 $47.5 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $34,998 - $38,718	-300 Reduced 0.09%	322,800 $38.1 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $867,478 - $1.02 Million	-8,200 Reduced 2.48%	323,100 $37.5 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $4.47 Million - $5.27 Million	41,100 Added 14.16%	331,300 $39.7 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $11.5 Million - $12.5 Million	109,200 Added 60.33%	290,200 $31.8 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $3.67 Million - $4.45 Million	40,000 Added 28.37%	181,000 $19.7 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $5.31 Million - $6.79 Million	69,300 Added 96.65%	141,000 $12.9 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $5.69 Million - $8.31 Million	-90,500 Reduced 55.8%	71,700 $5.66 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $1.28 Million - $1.42 Million	16,300 Added 11.17%	162,200 $14.1 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $2.68 Million - $2.9 Million	32,700 Added 28.89%	145,900 $12.2 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $2.93 Million - $3.42 Million	40,200 Added 55.07%	113,200 $9.52 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $741,664 - $896,672	11,200 Added 18.12%	73,000 $5.84 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $1.84 Million - $2.09 Million	28,100 Added 83.38%	61,800 $4.47 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $1.85 Million - $2.23 Million	30,400 Added 921.21%	33,700 $2.47 Million
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $189,981 - $209,682	3,300 New	3,300 $201,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.4 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.03 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.74 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.28 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account